Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Tysabri investigator confirms case of PML

March 9, 2005

Neuren and Metabolic Pharmaceuticals to codevelop neuroregenerative peptides

March 9, 2005

MYO-029 studied in new phase I/II trial for muscular dystrophy

March 9, 2005

Meta-analysis of the efficacy of melatonin as a sleep aid

March 8, 2005

Pioglitazone identified as a potential treatment for ALS

March 8, 2005

SB-649915: Novel 5-HT1A receptor antagonist with potent 5-HT reuptake inhibitory activity

March 8, 2005

MPTP and calcium: novel targets for the treatment of Huntington's disease

March 8, 2005

Novel dopamine/noradrenaline/serotonin reuptake inhibitors imparted by NeuroSearch

March 7, 2005

Two series of serotonin reuptake inhibitors reported by Merck

March 4, 2005

New title added to the Drug R&D Backgrounders topic list - Autism Spectrum Disorders

March 4, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...